Adjuvant chemotherapy outcomes of node negative, T1a, T1b, T1c hormone receptor-negative HER2-positive breast cancer patients

被引：0
|
作者：
Paul, Anu
Shi, Runhua
Peddi, Prakash
Burton, Gary
机构：
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.AM2017-2761
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2761
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Predictive factors of axillary lymph node metastasis in early (T1a and T1B) breast cancer
    Ali, I
    Witkiewicz, A
    Jaratli, H
    Edmiston, K
    Khan, A
    MODERN PATHOLOGY, 2002, 15 (01) : 25A - 25A
  • [32] Predictive factors of axillary lymph node metastasis in early (T1a and T1b) breast cancer
    Ali, I
    Witkiewicz, A
    Jaratli, H
    Edmiston, K
    Khan, A
    LABORATORY INVESTIGATION, 2002, 82 (01) : 25A - 25A
  • [33] T1a and T1b breast cancer: A twelve-year experience
    Visser, TJ
    Haan, M
    Keidan, R
    Lucas, R
    Ingold, J
    Glover, J
    Riggo, P
    AMERICAN SURGEON, 1997, 63 (07) : 621 - 626
  • [34] Disease-related outcomes with adjuvant chemotherapy in HER2 positive or triple negative T1a/bN0 breast cancers
    Shao, T.
    Olszewski, A. J.
    Boolbol, S. K.
    Migdady, Y.
    Boachie-Adjei, K.
    Sakr, B. J.
    Klein, P.
    Sikov, W.
    CANCER RESEARCH, 2012, 72
  • [35] Impact of adjuvant trastuzumab (T) with chemotherapy on breast cancer specific and cardiac outcomes in older women with small, node-negative HER2-positive breast cancer
    Cadoo, K. A.
    Morris, P. G.
    Patil, S.
    Norton, L.
    Hudis, C. A.
    McArthur, H. L.
    CANCER RESEARCH, 2013, 73
  • [36] Systemic Adjuvant Treatment of T1a and T1b NOMO HER2+Breast Carcinomas; an AERIO/UNICANCER Study.
    Peron, J.
    Vano, Y.
    Frenel, J-S
    Wassermann, J.
    Albiges, L.
    Rodrigues, M. J.
    Cottu, P. H.
    CANCER RESEARCH, 2011, 71
  • [37] Role of CD44 in nonpalpable T1a and T1b breast cancer
    Lyzak, JS
    Yaremko, ML
    Recant, W
    Baunoch, DA
    Joseph, L
    HUMAN PATHOLOGY, 1997, 28 (07) : 772 - 778
  • [38] Long-term results of T1a, T1b and T1c invasive breast carcinomas in Japanese women: Validation of the UICC T1 subgroup classification
    Ichizawa, N
    Fukutomi, T
    Iwamoto, E
    Akashi-Tanaka, S
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2002, 32 (03) : 108 - 109
  • [39] Loss of p27KIP1 Expression in Fully-staged Node-negative Breast Cancer: Association with Lack of Hormone Receptors in T1a/b, but not T1c Infiltrative Ductal Carcinoma
    Mirchandani, Deepu
    Roses, Daniel F.
    Inghirami, Giorgio
    Zeleniuch-Jacquotte, Anne
    Cangiarella, Joan
    Guth, Amber
    Safyan, Rachael Ann
    Formenti, Silvia C.
    Pagano, Michele
    Muggia, Franco
    ANTICANCER RESEARCH, 2011, 31 (12) : 4401 - 4405
  • [40] Is Oncotype DX test necessary for T1b grade 1, hormone receptor positive HER-2 negative breast cancer? A single institution retrospective analysis.
    Gudena, Vinay K.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
12345